1. Home
  2. ADX vs HRMY Comparison

ADX vs HRMY Comparison

Compare ADX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADX
  • HRMY
  • Stock Information
  • Founded
  • ADX 1840
  • HRMY 2017
  • Country
  • ADX United States
  • HRMY United States
  • Employees
  • ADX N/A
  • HRMY N/A
  • Industry
  • ADX Investment Managers
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADX Finance
  • HRMY Health Care
  • Exchange
  • ADX Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • ADX 2.3B
  • HRMY 2.1B
  • IPO Year
  • ADX N/A
  • HRMY 2020
  • Fundamental
  • Price
  • ADX $21.95
  • HRMY $36.87
  • Analyst Decision
  • ADX
  • HRMY Strong Buy
  • Analyst Count
  • ADX 0
  • HRMY 9
  • Target Price
  • ADX N/A
  • HRMY $55.33
  • AVG Volume (30 Days)
  • ADX 182.4K
  • HRMY 596.3K
  • Earning Date
  • ADX 01-01-0001
  • HRMY 08-05-2025
  • Dividend Yield
  • ADX 6.68%
  • HRMY N/A
  • EPS Growth
  • ADX N/A
  • HRMY 58.41
  • EPS
  • ADX N/A
  • HRMY 3.10
  • Revenue
  • ADX N/A
  • HRMY $772,527,000.00
  • Revenue This Year
  • ADX N/A
  • HRMY $20.45
  • Revenue Next Year
  • ADX N/A
  • HRMY $17.32
  • P/E Ratio
  • ADX N/A
  • HRMY $11.91
  • Revenue Growth
  • ADX N/A
  • HRMY 17.74
  • 52 Week Low
  • ADX $14.94
  • HRMY $26.47
  • 52 Week High
  • ADX $19.57
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • ADX 58.46
  • HRMY 61.50
  • Support Level
  • ADX $21.11
  • HRMY $32.64
  • Resistance Level
  • ADX $21.55
  • HRMY $36.74
  • Average True Range (ATR)
  • ADX 0.19
  • HRMY 1.18
  • MACD
  • ADX 0.02
  • HRMY 0.10
  • Stochastic Oscillator
  • ADX 87.50
  • HRMY 98.14

About ADX Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: